Delivery Order V797D50492-15B50923F00000216
Award Date
7/11/23
Potential Completion Date
8/1/23
Potential Value
$133K
Federal Agency
Federal Correctional Institution Fort Worth
Ultimate Awardee
Takeda Pharmaceutical Company LIMITED
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lexington, MA 02421, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth awarded Takeda Pharmaceuticals America Inc. a $99,865.35 firm fixed price delivery order against Takeda's Pharmaceuticals and Drugs GSA Schedule contract. Takeda will provide ADVATE and GAMMAGARD pharmaceutical products to the Bureau of Prisons facility in Lexington, Massachusetts by August 1, 2023 to support the agency's medical programs for inmates. No subcontractors or set aside designations were...
The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth awarded a firm fixed price delivery order contract to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company LIMITED, to provide the pharmaceutical products ADVATE and GAMMAGARD. The $134,959.80 contract was issued under Takeda's Pharmaceuticals and Drugs GSA Schedule contract with the government. No set-aside was used. Takeda Pharmaceutical Company LIMITED is a global...
The U.S. Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth awarded a firm fixed price delivery order to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company Limited, for the supply of ADVATE and GAMMAGARD specialty pharmaceutical products. The order, valued at $184,119.55, will be fulfilled by January 12, 2023. The contract was awarded under Takeda's existing Pharmaceuticals and Drugs General Services Administration (GSA) Schedule...
The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth awarded Takeda Pharmaceuticals America Inc. a $195,317.61 firm fixed price delivery order against Takeda's Pharmaceuticals and Drugs GSA Schedule contract. Takeda will provide ADVATE, a recombinant antihemophilic factor, to the Bureau of Prisons facility in Lexington, Massachusetts between August 15 and September 11, 2023. As the parent agency responsible for federal prisons, the Bureau of Prisons utilizes...
Takeda Pharmaceuticals America Inc. was awarded a $125,671.80 firm fixed price delivery order against its Pharmaceuticals and Drugs GSA Schedule contract by the Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth. The order is for FMC FORT WORTH TAKEDA MEDICATION for November 2023, with a completion date of February 27, 2024. No set-aside designation was applied. Takeda Pharmaceuticals America Inc. will leverage its parent company Takeda Pharmaceutical Company...
The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth has awarded a firm fixed-price delivery order to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company Limited, for medications valued at $98,465.40. The delivery order is placed against Takeda's Pharmaceuticals and Drugs General Services Administration (GSA) Federal Supply Schedule contract. Takeda specializes in providing specialty pharmaceutical products, including treatments...
The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth awarded a firm fixed-price delivery order to Takeda Pharmaceuticals America Inc., a subsidiary of Japanese pharmaceutical company Takeda Pharmaceutical Company Limited, to provide various specialty drug products through the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. The $124,865.40 order covers a range of critical medications used to treat conditions such as hemophilia,...
The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth awarded a $6,019.65 firm fixed price delivery order against Takeda Pharmaceuticals America Inc.'s Pharmaceuticals and Drugs Federal Supply Schedule contract. Takeda will provide ADVATE and GAMMAGARD pharmaceutical products to the correctional facility in Lexington, Massachusetts between August 1st and September 6th, 2023. As the largest correctional agency in the U.S., the Bureau of Prisons is responsible for...
This federal contract award was made by the Federal Correctional Institution Fort Worth, a civilian agency, to Takeda Pharmaceuticals America Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $109,885.84 firm fixed-price delivery order contract, which has no set-aside designation, is for the delivery of specialized medications to the agency. The contract is associated with the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule (FSS-61-IB) and...
This federal contract award is a delivery order valued at $113,436.24 issued by the Federal Correctional Institution (FCI) Fort Worth, a civilian agency, to Takeda Pharmaceuticals America Inc. under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule contract. The order is for a variety of Takeda's specialty pharmaceutical products, including treatments for hemophilia, immune deficiencies, hereditary angioedema, and cancer, to be delivered to the FCI Fort Worth...